Nexobrid Market Report 2026
Epidemiology, Pipeline Analysis, Market Insights & Forecasts
Nexobrid Market Overview
• The Nexobrid market growth in the historic period has been driven by increasing incidence of severe burn injuries, limitations of surgical debridement methods • Market expansion is supported by increasing demand for minimally invasive wound management, expansion of trauma care infrastructure • Growth Driver: Rising Prevalence Of Burn Injuries To Drive The Market Growth • Market Trend: Enhancing Emergency Preparedness With Advanced Burn Care Treatments • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Nexobrid Market?
Nexobrid is a topical enzymatic debridement agent designed to treat severe burns. It selectively removes eschar while preserving healthy tissue, accelerating wound healing, and minimizing the need for surgical procedures. This advanced formulation enhances recovery outcomes and offers a non-invasive solution for burn care. The main types of nexobrid formulations are topical gel, spray, and ointment. A topical gel formulation is designed for direct skin application, promoting healing by delivering active ingredients efficiently to the affected area. It is applicable in several clinical indications, such as burn care, chronic wound care, and trauma care, and is distributed through various distribution channels, including hospitals, ambulatory surgical centers (ASCs), retail pharmacies, and online pharmacies, and is used by several end users, such as adults, pediatrics, and geriatrics.
What Is The Nexobrid Market Size and Share 2026?
The growth in the historic period can be attributed to increasing incidence of severe burn injuries, limitations of surgical debridement methods, expansion of specialized burn care units, rising awareness of advanced wound care therapies, improved access to topical enzymatic treatments.What Is The Nexobrid Market Growth Forecast?
The growth in the forecast period can be attributed to increasing demand for minimally invasive wound management, expansion of trauma care infrastructure, growing adoption of advanced enzymatic formulations, rising focus on patient recovery outcomes, increasing investments in next-generation burn care technologies. Major trends in the forecast period include increasing adoption of enzymatic burn debridement solutions, rising demand for non-surgical burn care treatments, growing focus on accelerated wound healing, expansion of advanced trauma and burn centers, enhanced emphasis on tissue preservation.
Global Nexobrid Market Segmentation
1) By Formulation: Topical Gel, Spray, Ointment 2) By Clinical Indication: Burn Care, Chronic Wound Care, Trauma Care 3) By Distribution Channel: Hospitals, Ambulatory Surgical Centers (ASCs), Retail Pharmacies, Online Pharmacies 4) By End-User: Adult, Pediatric, GeriatricWhat Is The Driver Of The Nexobrid Market?
The increasing prevalence of burn injuries is expected to fuel the growth of the nexobrid market going forward. Burn injuries refer to physical damage to the skin or other tissues leading to tissue destruction, pain, and impaired function. Occupational hazards in industries such as construction, manufacturing, and healthcare increase burn injury risks due to exposure to open flames, hot surfaces, and hazardous chemicals. Nexobrid aids in burn recovery by efficiently removing eschar from burn wounds, accelerating healing, and minimizing the need for surgery, ultimately enhancing patient outcomes. For instance, in October 2023, according to a report published by the World Health Organization, a Switzerland-based intergovernmental organization, approximately 180,000 deaths occur annually due to burns, with the majority happening in low- and middle-income countries. Therefore, the increasing prevalence of burn injuries will drive the nexobrid industry growth.Key Players In The Global Nexobrid Market
Major companies operating in the nexobrid market are MediWound Ltd.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Nexobrid Market Trends and Insights
Major companies operating in the NexoBrid market are focusing on developing innovative solutions, such as eschar removal drugs, to meet the rising demand for effective, non-invasive burn care solutions. These drugs break down dead tissue (eschar) while preserving healthy tissue, providing a non-surgical alternative to traditional debridement. For instance, in August 2024, MediWound Ltd., an Israel-based biopharmaceutical company, announced that the U.S. FDA had approved NexoBrid (anacaulase-bcdb) for pediatric patients with deep partial-thickness or full-thickness thermal burns. The product features a proteolytic enzyme formulation that removes burn eschar within four hours, supports tissue regeneration, and reduces the need for surgical intervention. NexoBrid is approved in over 43 countries and is supported by BARDA.What Are Latest Mergers And Acquisitions In The Nexobrid Market?
In November 2024, MediWound Ltd., an Israel-based provider of enzymatic debridement products and advanced wound care therapies, partnered with PolyMedics Innovations to enhance wound care solutions. With this partnership, MediWound aims to expand the commercial reach of its NexoBrid product across key European markets, strengthen adoption in burn care centers, and complement PMI’s existing wound-healing product portfolio. PolyMedics Innovations GmbH is a Germany-based provider of advanced wound care and skin substitute solutions, including products such as SUPRATHEL and NovoSorb BTM.
Regional Insights
North America was the largest region in the nexobrid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.Need data for a specific geography? Request Regional Data
What Defines the Nexobrid Market?
The nexobrid market consists of sales of cream, liquid solution, and powder. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Nexobrid Market Report 2026?
The nexobrid market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nexobrid industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Nexobrid Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | - |
| Revenue Forecast In 2030 | - |
| Growth Rate | - |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Formulation, Clinical Indication, Distribution Channel, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | MediWound Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |